Novel Protein Footprinting Technology for Reproducible HRPF Experiments
Novel Protein Footprinting Technology for Reproducible HRPF Experiments May 24 2021 GenNext Technologies, Inc, a growth-stage company that provides instrumentation, software, and services to structural biology researchers within the biopharmaceutical industry, announced today that nearly US$7 million in NIH grant awards has led to a seminal US patent for its novel technology that vastly improves the utility of protein footprinting for the study of biopharmaceutical higher order structure. GenNext Technologies is honored to have earned a total of nine National Institute of Gene...
Source: labmate-online.com